PEAK6 LLC Acquires Shares of 18,389 The Cooper Companies, Inc. $COO

PEAK6 LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 18,389 shares of the medical device company’s stock, valued at approximately $1,319,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Avalon Trust Co purchased a new position in Cooper Companies in the second quarter worth $25,000. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares during the last quarter. SJS Investment Consulting Inc. increased its position in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the last quarter. Elevation Wealth Partners LLC raised its stake in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after purchasing an additional 375 shares during the period. Finally, J.Safra Asset Management Corp bought a new stake in shares of Cooper Companies during the 2nd quarter worth $32,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $76.22 on Monday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $14.87 billion, a PE ratio of 64.59, a P/E/G ratio of 1.99 and a beta of 0.83. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a 50-day moving average price of $71.93 and a two-hundred day moving average price of $71.09.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on COO shares. UBS Group started coverage on shares of Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target for the company. Citigroup reaffirmed a “neutral” rating and issued a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. Robert W. Baird reduced their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Finally, Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.